No area of technology presents more complex intellectual property issues than biotechnology and life sciences.

One reason is the rapid development of scientific disciplines, such as molecular biology, microbiology, cell biology, etc., which produce novel subject matter to be protected. 

Examples include cloned genes, nucleic acid probes, transgenic plants, gene chips, enzymes, and the uses of many of these novel materials.

Another reason is that intellectual property law has changed remarkably since the 1980 landmark Supreme Court decision in the Chakrabarty case which held that living organisms are patentable subject matter.

Many of the developments in intellectual property law have a unique application to biotechnology, such as the laws and regulations relating to biological deposits, sequence listings, patentability of ESTs, and the nonobviousness of biotechnology processes.

Our firm has earned its reputation based on the extensive training and experience, both scientific and legal, of its professional staff.

We strive to obtain for our clients the best protection available through a thorough and creative approach in preparing and prosecuting patent applications, negotiating and drafting license agreements, collaborative research, development and marketing agreements, materials transfer agreements and other types of agreements relating to biotechnology.

The scientific education and industry experience, coupled with the legal education and experience of our attorneys and technical advisors, enables us to develop unique strategies to protect our clients' inventions.

Useful links:

  • Biotechnology Industry Organization (BIO): www.bio.org

Copyright 2023 Jondle & Associates - All rights reserved